Optiscan said clinical studies for the first surgical indication in breast cancer surgery are expected to commence in Melbourne and the US over the coming months, to collect suitable data for a US Food and Drug Administration regulatory submission.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)